Drug Information Association Logo

Complimentary Patient-Centeredness and Engagement in Clinical Research: Opportunities for Industry

| Online

« Back to Listing


Continuing Education credit is not available for archived webinars.

This archive will be available through January 31, 2015.
Archive duration: 1 hour 28 minutes


DIA membership is not required to register for this complimentary webinar. 

Pfizer Executive Vice President and Chief Medical Officer and PCORI Board of Governors Member Freda Lewis-Hall, MD, recently noted that “it seems counterintuitive that ‘patient-centered’ drug development is now a hot-button issue for those of us involved in new therapies. Drug development should be patient centered—we all want medicines to be safe, as defined by their benefits versus their risks, and we want them to be effective for the patient.” The excitement about the idea of being “patient-centered,” she notes, comes from the growing recognition that patient views and values can, and should, be captured and integrated in new ways –technological and otherwise – in the drug development process.

As Lewis-Hall says, many in the research community now believe that scientific inquiry in drug development should go beyond “safe and effective”— essential as these are — to focus on outcomes that patients themselves tell us are meaningful ones. In this PCORI-DIA webinar, we’ll look at how PCORI and others are advancing patient-centeredness and engagement in research, what we know so far about the impact of this trend, what we hope to learn in the future, and implications for industry.

This webinar was developed in collaboration with the Patient-Centered Outcomes Research Institute (PCORI)


For more information on PCORI, please visit their website here.

Who Should Attend 

This webinar is open to any individual with an interest in the subject, including, but not limited to, patients, clinicians, payers, purchasers and industry representatives. The content is specifically designed for professionals with intermediate to advanced knowledge of, and experience in:

  • Clinical Research
  • Comparative Effectiveness/Health Technology Assessment/Evidence-based Medicine
  • Regulatory Affairs
  • Quality Assurance/Quality Control
  • Medical Writing

Learning Objectives 

At the conclusion of this webinar, participants should be able to:

  • Discuss how PCORI and other stakeholders are advancing patient-centeredness and engagement in clinical research
  • Explain how patient engagement will impact the clinical trial process
  • Discuss the implications for industry with this clinical research paradigm shift

Special Offers 

This is a complimentary archived webinar. Please complete online registration to receive playback information.

Contact Information 

Printable Registration Form

Registration Questions
Toll Free 1.888.257.6457
Phone +1.215.442.6100
Fax +1.215.442.6199
Monday-Friday 8:30AM-8:00PM ET

For information regarding this webinar
Carolyn Callahan
Phone +1.215.442.6194
Fax +1.215.442.6199

Technical Requirements 

Click here for minimum system requirements.


Previous Next

Registration Fees 

Other Fees

Group Discounts\Registration

There is no group discount for this meeting

DIA membership not required to register for this complimentary webinar.

Cancellations:  No refunds will be provided in the event of a participant’s cancellation since all costs for this webinar have been prepaid by DIA. DIA reserves the right to modify or cancel programs and/or substitute presenters or panelists. DIA is not responsible for failure to deliver programs due to circumstances beyond its control.

Participants with Disabilities: Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.

Register Online

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top